Detecting cancer with anti-CCL25 and anti-CCR9 antibodies
US8658377B2 · kind B2 · utility
6Cited by
39References
5Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 13, 2011 |
| Grant date | Feb 25, 2014 |
| Priority date | — |
| Expiry date | Dec 13, 2031 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2333/7158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
Methods for detecting cancer in a subject are disclosed. The method includes detecting the level of expression of one or more cancer markers in a biological sample obtained from the subject; and comparing the level of expression of the one or more cancer markers in the biological sample to a normal level of expression of the one or more cancer markers. The one or more cancer markers comprise CCL25 or CCR9 or both CCL25 and CCR9.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.